Godrej Consumer Q1 Results Review - Improvement Continues In Home Care Segment; 'Reduce': Dolat Capital

Dolat Capital Report

Godrej Consumer Products Ltd.’s Q1 FY24 revenues were in line with our estimate but profitability was a miss. The company reported 12% volume growth in India business.

During the quarter, Godrej Consumer Products reported positives related to –

1. second consecutive quarter of double digit growth in household insecticide portfolio,

2. Indonesia witnessed 15% constant currency growth with 20% Rs growth,

3. secondary sales in Raymond Consumer Care Ltd. was two times plus of primary sale.

However, mere 2% growth in personal care portfolio was a disappointment.

We have revised our FY24/25E earnings per share estimates at Rs 20.3/23.6 to factor in Q1 performance. Though Indonesia and HI performance revamped during the quarter, we await for consistency in performance.

Valuing the stock at 44 times FY25E EPS we arrive at target price of Rs 1,051. Maintain 'Reduce'.

Click on the attachment to read the full report:

DISCLAIMER

This report is authored by an external party. BQ Prime does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BQ Prime.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.